Zobrazeno 1 - 10
of 170
pro vyhledávání: '"400 MG"'
Publikováno v:
International Journal of Infectious Diseases, Vol 117, Iss , Pp 48-55 (2022)
Background: Efavirenz (EFV) 400 mg has been recommended to replace EFV 600 mg. There are only 200 mg and 600 mg dosage forms of EFV in China. Whether switching from one-tablet EFV 600 mg to two-tablet EFV 200 mg would weaken adherence or further affe
Externí odkaz:
https://doaj.org/article/5191498f31ae4737ab8a10f87c18b06a
Autor:
Ling Xu, Wenxiu Peng, Xiaojing Song, Yanling Li, Yang Han, Ting Zhu, Qiang Fu, Xiaoli Du, Wei Cao, Taisheng Li
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The plasma concentration of patients treated with efavirenz (EFV) 600 mg was found to exceed the upper limit of the proposed therapeutic window in most Chinese HIV-infected individuals; thus, dosage reduction of EFV to 400 mg dail
Externí odkaz:
https://doaj.org/article/c426d6bb611a401f8bfdc13af982ff8b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
V V Korennaya
Publikováno v:
Гинекология, Vol 17, Iss 1, Pp 55-58 (2015)
Primary dysmenorrhea is one of the most common forms of menstrual disorders in young age. This often leads to disablement of patients for several days and requires high-speed and efficient preparations. The first line of therapy in primary dysmenorrh
Externí odkaz:
https://doaj.org/article/b1a158d6d1fa4ac7b6446b9426d3fc0f
Publikováno v:
World Journal of Clinical Cases
Background The incidence of infection with Mycobacterium abscessus (M. abscessus) has increased in recent years. This increase is partly associated with invasive cosmetic procedures. Case summary The purpose of this case summary is to increase clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0d131be09ad6ab5edf4e98db064381
http://europepmc.org/articles/PMC7953399
http://europepmc.org/articles/PMC7953399
Autor:
Yanling Li, Yang Han, Ling Xu, Wenxiu Peng, Taisheng Li, Qiang Fu, Xiaoli Du, Ting Zhu, Wei Cao, Xiaojing Song
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background The plasma concentration of patients treated with efavirenz (EFV) 600 mg was found to exceed the upper limit of the proposed therapeutic window in most Chinese HIV-infected individuals; thus, dosage reduction of EFV to 400 mg daily warrant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed8616e5bdd00ef448b0730658a1e70
https://doaj.org/article/c426d6bb611a401f8bfdc13af982ff8b
https://doaj.org/article/c426d6bb611a401f8bfdc13af982ff8b
Autor:
V.S. Sukachev, K. V. Zhdanov, E.А. Klimova, S N Batskikh, D.A. Gusev, Vasily Kropochev, E.P. Tarkhova, O. O. Znoyko, N. D. Yushchuk, E.N. Krasavina, M.Yu. Samsonov, Vasily Isakov, Svetlana Kizhlo, K. V. Kozlov
Publikováno v:
Infectious diseases: News, Opinions, Training. 9:41-48
Aim of investigation - to estimate efficacy and safety of direct-acting antivirus agents narlaprevir/ritonavir and sofosbuvir in non-cirrhotic patients with chronic hepatitis C Material and methods Treatment naive patients with chronic HCV infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22582eb06c638529f4d3b0366b4e0beb
https://doi.org/10.33029/2305-3496-2020-9-3-41-48
https://doi.org/10.33029/2305-3496-2020-9-3-41-48
Autor:
Sílvia Regina Cavani Jorge Santos, Mara Cristina da Silva Martins Pappalardo, Grazziela Samantha Perez, Cristina Sanches-Giraud, Márcia de Souza Carvalho Melhem
Publikováno v:
Revista Portuguesa de Farmacoterapia, Vol 4, Iss 4, Pp 19-22 (2012)
Objectives: To determine whether amphotericin B (AmB) and fluconazole cross the blood-brain barrier in a similar manner in patients with HIV-associated cryptococcal meningitis based on the cerebrospinal fluid (CSF)/plasma drug ratio through a compara
Externí odkaz:
https://doaj.org/article/26659f03b97d444086a2afdcc3050ebc
Publikováno v:
Clinical Pharmacology: Advances and Applications. 11:93-101
Objective: Delayed-release mesalamine 400 mg capsules containing four 100 mg tablets have been developed for children with ulcerative colitis who have difficulty swallowing. Bioavailability of the mesalamine capsules was compared with existing mesala
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcef6cf0da12c780980e16e4677f50fd
https://doi.org/10.2147/cpaa.s193191
https://doi.org/10.2147/cpaa.s193191
Autor:
Heba Omar, Aisha Elsharkawy, Walid Kamal, Hassan El-Garem, Neveen H. Abou El-Soud, Mohamad A Mohey Eldin Elzahry, Ahmed Cordie, Mohamed AbdAllah, Gamal Esmat, Shereen Abdel Alem, Doaa Ghaith
Publikováno v:
Expert Review of Gastroenterology & Hepatology. 13:693-698
Background: The present work aimed at evaluation of the potential dynamic changes in hepatic fibrosis following treatment of chronic HCV using DAAs in patients coinfected with HIV. Patients and methods: In total, 50 HCV/HIV coinfected patients [age;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb88f538474a583469a7f58d42f1e027
https://doi.org/10.1080/17474124.2019.1614441
https://doi.org/10.1080/17474124.2019.1614441